Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
The enzyme-linked immunosorbent assay indicated to a plate-based antibody assay method. Which is used for the detection and measurement of concentration of antigens, peptides, proteins, antibodies and hormones in the testing samples. In the ELISA method the antigen or the testing element is made immobilised or restrained on the solid surface and it is further reacted with a specified antibody which linked to the enzymes. Additionally, with the addition of specific substrate, the enzyme reacts with it and produces a distinguishing odour. The development of colour confirms the occurrence of antigen or the different colour texture confirms the antigen concentrations.
The global Enzyme-linked immunosorbent assay market is anticipated to grow at CAGR of 4.89% during the forecast period of 2019 - 2028. The ELISA test is performed for detection of presence of antibodies in a biological liquid sample. The key factors such as growing prevalence of infectious diseases is propelling growth of Enzyme-linked immunosorbent assay market. The rising need for cost-effective diagnostic tools is also boosting growth of Enzyme-linked immunosorbent assay. However, availability of other immunoassay techniques is restraining the growth of Enzyme-linked immunosorbent assay market.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the Enzyme-linked immunosorbent assay market. In addition, complete analysis of changes on Enzyme-linked immunosorbent assay expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The COVID-19 has almost affected every market is healthcare industries positively or negatively. The rising cases of COVID-19 and adoption of technically advanced test for detection of infectious diseases in patients is rising demand of Enzyme-linked immunosorbent assay. The Enzyme-linked immunosorbent assay test is more sensitive than other tests for detection of infectious disease in patients. Thereby, the Enzyme-linked immunosorbent assay market has positive impact of COVID-19.
The Enzyme-linked immunosorbent assay market is segmented into type, application, end user and geography.
The Enzyme-linked immunosorbent assay market is comprised of various type of ELISA such as sandwich ELISA, indirect ELISA, direct ELISA, competitive ELISA. In which indirect ELISA is estimated to dominate the market in 2020. The indirect ELISA test is also called as two step ELISA which includes two binding process of primary antibody and labelled secondary antibody. The primary antibody is incubated with antigen followed by the incubation with the secondary antibody.
The Enzyme-linked immunosorbent assay market have various applications in the vaccine development, immunology, diagnostics, toxicology, drug monitoring and pharmaceuticals and transplantation. In which diagnostic applications are expected to dominate the market in 2020. The rising incidences of infectious diseases is propelling growth of Enzyme-linked immunosorbent assay market. The rising demand for early diagnostic is also boosting growth of Enzyme-linked immunosorbent assay market. The Enzyme-linked immunoassay test is used for the diagnosis of cancer, HIV AIDS, inflammation disorders, protein quantification and other. Which makes them more demandable in the market.
The Enzyme-linked immunosorbent assay market is comprised of end user such as hospital and diagnostic centres, research laboratories and other. In which hospital and diagnostic centres are likely to dominate the market in 2020. The rising flow of patients in hospital and diagnostic centres is propelling growth of Enzyme-linked immunosorbent assay market. The growing number of hospitals and diagnostic centres is also boosting growth of Enzyme-linked immunosorbent assay market. The rising demand for quality testing is also refuelling growth of Enzyme -linked immunosorbent assay market.
The Enzyme-linked immunosorbent assay market is studied for various countries of regions such as North America, Europe, Asia Pacific and Rest of the World. The North America is anticipated to dominate the market in 2020. The rising healthcare expenditures is boosting growth of Enzyme-linked immunosorbent assay market. The growing technological advancements is also propelling the growth of Enzyme-linked immunosorbent assay market. The rising prevalence of infectious diseases is also driving growth of Enzyme-linked immunosorbent assay market.
The major key players of Enzyme-linked immunosorbent assay market are Alpco, Abcam Plc, Agilent Technologies Inc., BD Biosciences, Bio-Rad Laboratories Inc., Biolegend Inc., Enzo Life Sciences Inc., F. Hoffmann-La Roche Ltd., Merck Kgaa, Mercodia Ab, Ortho-Clinical Diagnostics Inc., Perkinelmer Inc., Qiagen Nv, R&D Systems Inc., Shenzen Yhlo Biotech Co. Ltd., Thermo Fischer Scientific Inc., Zeus Scientific, Inc. and Biomérieux Sa among others.
February 2021: The Thermo Fisher Scientific Inc., acquired the private point of care molecular diagnostic company named as Mesa Biotech.
February 2020: The Becton Dickinson and Co. reported a collaborated with Babson Diagnostic for bringing lab quality, little volume blood assortment to retail drug stores.
March 2018: BARD1 Life sciences, The U.S. based science research company is expected the commercialization of BARD1-Ovarian blood based ELISA test for distinguishing ovarian diseases in the beginning phase.
January 2018: The Eagle Biosciences Inc., presented a novel unblemished FGF23 ELISA unit test which is the 96 well sandwich ELISA examination. It is estimated as full-length dynamic type of human Intact FGF23 utilized for the discovery of mineral bone disorder, chronic kidney disorder, chronic kidney disease and hyperphosphatemia.
The report analyses the Enzyme-linked immunosorbent assay market based on type, application, end user and geography. The various type of ELISA test covered in the report are sandwich ELISA, indirect ELISA, direct ELISA and competitive ELISA. By application, the market is segmented into the vaccine development, immunology, diagnostics, toxicology, drug monitoring and pharmaceuticals and transplantation. Based on end user, the market is segmented into the hospital and diagnostic centre, research laboratories and other. The report also analyses the impact of COVID-19 on the Enzyme-linked immunosorbent assay market and it is analyses that the COVID-19 has almost affected every market is healthcare industries positively or negatively. The rising cases of COVID-19 and adoption of technically advanced test for detection of infectious diseases in patients is rising demand of Enzyme-linked immunosorbent assay. The Enzyme-linked immunosorbent assay test is more sensitive than other tests for detection of infectious disease in patients. Thereby, the Enzyme-linked immunosorbent assay market has positive impact of COVID-19. The report also covers the major key players operating in the market.
Why to buy this report
